| DIRECT COMPETITOR COMPARISON | |
| BCRA.OB | Pvt1 | OFIX | OSTE | Industry | | Market Cap: | N/A | N/A | 512.68M | 47.93M | N/A | | Employees: | N/A | 7,2201 | 1,418 | 331 | N/A | | Qtrly Rev Growth (yoy): | N/A | N/A | 4.50% | -4.60% | N/A | | Revenue (ttm): | N/A | 2.13B1 | 533.92M | 94.93M | N/A | | Gross Margin (ttm): | N/A | N/A | 74.45% | 49.91% | N/A | | EBITDA (ttm): | N/A | N/A | 83.37M | 1.70M | N/A | | Oper Margins (ttm): | N/A | N/A | 11.00% | -4.81% | N/A | | Net Income (ttm): | N/A | -964.20M1 | 14.29M | -5.32M | N/A | | EPS (ttm): | N/A | N/A | 0.833 | -0.296 | N/A | | P/E (ttm): | N/A | N/A | 35.92 | N/A | N/A | | PEG (5 yr expected): | N/A | N/A | 0.85 | N/A | N/A | | P/S (ttm): | N/A | N/A | 1.00 | 0.51 | N/A |
|
| Pvt1 = Biomet, Inc. (privately held) | | OFIX = Orthofix International NV | | OSTE = Osteotech, Inc. | | 1 = As of 2008 |
| NEWS ON DIRECT COMPETITORS | |
| | OFIX | | Medical Products Maker Has High Hopes For New Bone Treatment Fri, Nov 20 -
Investor's Business Daily | | | OFIX | | Moody's and S&P Improve Ratings Outlook for Orthofix International Thu, Nov 19 -
Business Wire | | | OSTE | | OSTEOTECH INC Financials Fri, Nov 13 -
EDGAR Online Financials | | | OFIX | | Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps Wed, Nov 11 -
PR Newswire | | | OFIX | | ORTHOFIX INTERNATIONAL N V Financials Wed, Nov 11 -
EDGAR Online Financials | | | OSTE | | Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting Wed, Nov 11 -
PR Newswire | | | OSTE | | OSTEOTECH INC Files SEC form 10-Q, Quarterly Report Mon, Nov 9 -
EDGAR Online | | | OSTE | | CVR Energy, Osteotech: Biggest Price Decliners (CVI, OSTE) Fri, Nov 6 -
at The Wall Street Journal Online | | | OFIX | | ORTHOFIX INTERNATIONAL N V Files SEC form 10-Q, Quarterly Report Fri, Nov 6 -
EDGAR Online | | | OSTE | | OSTEOTECH INC Files SEC form 8-K, Results of Operations and Financial Condition Fri, Nov 6 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|